Nemaura Medical to Present at the 2015 Marcum Microcap Conference

Nemaura Medical Inc. (OTC BB: NMRD), a leading developer of minimally-invasive transdermal diagnostic technologies, announced today that Dr. D F Chowdhury, CEO, and Bashir Timol, Commercial Director, will be presenting at the 2015 Marcum Microcap Conference, which will take place May 27th to May 28th at the Grand Hyatt Hotel in New York City.

Management’s presentation will take place on Thursday, May 28th at 2:30 p.m. Eastern Time in the Imperial Room.

The Company’s presentation will cover their first product called ‘sugarBEAT’, a painless, minimally invasive Continuous Glucose Monitoring solution targeting diabetics. The sugarBEAT system consists of a disposable sensor patch that is worn around the arm or thigh, connected to a watch device and smartphone App.

The annual Marcum MicroCap Conference is a showcase for public companies with less than $500 million in market capitalization. For more information or to register, please visit the conference website at http://www.marcumllp.com/microcap.

About Nemaura Medical

Nemaura Medical Inc. is developing smart non-invasive medical diagnostic devices for the global healthcare market. Their first product is a painless, minimally invasive Continuous Glucose Monitoring solution targeting diabetics called ‘sugarBEAT’. The sugarBEAT system consists of a disposable sensor patch that is worn around the arm or thigh, connected to a watch device and smartphone App. SugarBEAT has completed thus far a 100 patient day clinical study and is anticipated for CE approval and launch in the UK and Saudi Arabia by early 2016. The Company is further exploring the use of its technology for use in critical care continuous glucose monitoring.